Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q416361> ?p ?o }
Showing triples 1 to 42 of
42
with 100 triples per page.
- Q416361 subject Q5920511.
- Q416361 subject Q7139608.
- Q416361 subject Q7158320.
- Q416361 subject Q7335370.
- Q416361 subject Q7441579.
- Q416361 subject Q9052268.
- Q416361 abstract "Pyritinol also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of vitamin B6 (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B6 compounds (pyridoxine) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders and learning disorders in children. Since the early 1990s it has been sold as a nootropic dietary supplement in the United States.It is approved for "symptomatic treatment of chronically impaired brain function in dementia syndromes" and for "supportive treatment of sequelae of craniocerebral trauma" in various European countries, including Austria, Germany, France, Italy, Portugal, and Greece.In France it is also approved for rheumatoid arthritis as a disease modifying drug, on the basis of the results of clinical trials.It is not licensed for use in the United Kingdom, but in many countries it is available over the counter and is widely advertised on the internet as being for "memory disturbances." From the known sales data, it is estimated that more than 100 000 individuals in European Union countries have taken pyritinol in the past five years.One small study, with 12 subjects given pyritinol, showed an improvement in performance on tests of reaction time, but not on memory tests.Some studies have found large doses of Pyritinol can help to reduce hangovers.".
- Q416361 atcPrefix "N06".
- Q416361 atcSuffix "BX02".
- Q416361 casNumber "1098-97-1".
- Q416361 fdaUniiCode "AK5Q5FZH2R".
- Q416361 iupacName "5,5'-[dithiobis(methylene)]bis[4-(hydroxymethyl)-2-methylpyridin-3-ol]".
- Q416361 pubchem "14190".
- Q416361 thumbnail Pyritinol.svg?width=300.
- Q416361 wikiPageWikiLink Q1075923.
- Q416361 wikiPageWikiLink Q131742.
- Q416361 wikiPageWikiLink Q187255.
- Q416361 wikiPageWikiLink Q205130.
- Q416361 wikiPageWikiLink Q2581447.
- Q416361 wikiPageWikiLink Q5920511.
- Q416361 wikiPageWikiLink Q7139608.
- Q416361 wikiPageWikiLink Q7158320.
- Q416361 wikiPageWikiLink Q7198015.
- Q416361 wikiPageWikiLink Q7335370.
- Q416361 wikiPageWikiLink Q742487.
- Q416361 wikiPageWikiLink Q7441579.
- Q416361 wikiPageWikiLink Q810254.
- Q416361 wikiPageWikiLink Q9052268.
- Q416361 atcPrefix "N06".
- Q416361 atcSuffix "BX02".
- Q416361 casNumber "1098".
- Q416361 iupacName "55".
- Q416361 pubchem "14190".
- Q416361 unii "AK5Q5FZH2R".
- Q416361 type ChemicalSubstance.
- Q416361 type Drug.
- Q416361 type ChemicalObject.
- Q416361 type Thing.
- Q416361 type Q8386.
- Q416361 comment "Pyritinol also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of vitamin B6 (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B6 compounds (pyridoxine) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders and learning disorders in children.".
- Q416361 label "Pyritinol".
- Q416361 depiction Pyritinol.svg.